Canabo Medical Inc Sets 52-Week Low; Strong Momentum for Sellers

 Canabo Medical Inc Sets 52 Week Low; Strong Momentum for Sellers

The stock of Canabo Medical Inc (CVE:CMM) hit a new 52-week low and has $0.87 target or 14.00% below today’s $1.01 share price. The 6 months bearish chart indicates high risk for the $2.63 million company. The 1-year low was reported on Nov, 15 by If the $0.87 price target is reached, the company will be worth $368,200 less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 120,821 shares traded hands or 76368.99% up from the average. Canabo Medical Inc (CVE:CMM) has risen 6.00% since October 16, 2016 and is uptrending. It has outperformed by 2.07% the S&P500.

More important recent Canabo Medical Inc (CVE:CMM) news were published by: which released: “Canabo Medical Inc. Announces Completion of Change of Name, Share …” on November 09, 2016, also published article titled: “Four River Ventures Ltd. Announces Proposed Reverse Takeover With Canabo …”, published: “Four River Ventures Ltd. Announces Financing Update Concerning Canabo Medical …” on September 29, 2016. More interesting news about Canabo Medical Inc (CVE:CMM) was released by: and their article: “Tweed Looks to Control Nearly Half of Canadian Cannabis Market” with publication date: September 15, 2015.

Canabo Medical Inc, formerly Four River Ventures Ltd, is a Canada company, which is engaged in the provision of medical services and non-cannabinoid products for patients suffering from chronic pain and disabling illnesses through health clinics. The company has a market cap of $2.63 million. The Firm operates approximately 10 medical clinics across Canada. It has a 238.21 P/E ratio. The Company’s medical clinics are operated by qualified health care practitioners, independent medical marijuana evaluations for employers and insurers, and medical marijuana scientific research.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment